QUEST DIAGNOSTICS INC DGX
NYSE · XNYS · stock · Services-Medical Laboratories
Chart by TradingView
6/9
Piotroski F — financial health
3.52
Altman Z″ — distress risk · safe
35.6%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $11.0B | $992.0M | — | $1.4B | $7.2B |
| 2024 | $9.9B | $871.0M | — | $909.0M | $6.8B |
| 2023 | $9.3B | $854.0M | — | $864.0M | $6.3B |
| 2022 | $9.9B | $946.0M | — | $1.3B | $5.9B |
| 2021 | $10.8B | $2.0B | — | $1.8B | $6.5B |
| 2020 | $9.4B | $1.4B | $3.6B | $1.6B | $6.8B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 2026-06-04 | Option exercise | 3,320 | $127.72 |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 2026-06-04 | Option exercise | 4,827 | $121.81 |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 2026-06-04 | Sell | 8,147 | $200.00 |
| Davis J. E. | CEO and President | 2026-06-01 | Sell | 10,000 | $194.14 |
| CARTER ROBERT B | director | 2026-05-20 | Grant | 1,142 | — |
| Gregg Vicky B | director | 2026-05-20 | Grant | 1,142 | — |
| Diaz Luis | director | 2026-05-20 | Grant | 1,142 | — |
| MAIN TIMOTHY L | director | 2026-05-20 | Grant | 1,142 | — |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.52 (safe)
- Working capital / assets 0.006
- Retained earnings / assets 0.616
- EBIT / assets 0.096
- Equity / liabilities 0.792
Source: SEC EDGAR filings · CIK 0001022079 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.